ClearPoint Neuro (CLPT) Income from Continuing Operations (2011 - 2026)

ClearPoint Neuro's (CLPT) quarterly Income from Continuing Operations came in at 9552000.0 in Q1 2026, down 58.51% year-on-year from 23024140.8 in Q1 2025, and down 22.68% quarter-over-quarter from 7786000.0 in Q4 2025.

ClearPoint Neuro (CLPT) Income from Continuing Operations (2011 - 2026) Analysis & Trends

ClearPoint Neuro has disclosed Income from Continuing Operations across 15 years of filings, most recently posting 9552000.0 for Q1 2026.

  • Income from Continuing Operations for Q1 2026 came in at 9552000.0, down 58.51% year-over-year; the trailing twelve-month figure through Mar 2026 was 29066000.0 (down 39.78% YoY), and the FY2025 annual result was 25540000.0, down 35.03% from the prior year.
  • Income from Continuing Operations came in at 9552000.0 for Q1 2026 at ClearPoint Neuro, down from 7786000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 3795000.0 in Q3 2022 to a low of 9552000.0 in Q1 2026.
  • The 5-year median for Income from Continuing Operations is 4974000.0 (2024), against an average of 5469470.59.
  • Across the five-year window, Income from Continuing Operations slumped 66.03% in 2023 and jumped 38.19% in 2024, its largest moves.
  • ClearPoint Neuro's Income from Continuing Operations stood at 4469000.0 in 2022, then retreated by 5.3% to 4706000.0 in 2023, then dropped by 14.45% to 5386000.0 in 2024, then plunged by 44.56% to 7786000.0 in 2025, then slipped by 22.68% to 9552000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 9552000.0 (Q1 2026), 7786000.0 (Q4 2025), and 5891000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.08 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 745.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 380.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 273.95 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 411.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 220.30 Mn
10 ClearPoint Neuro 524.46 Mn 488.86 Mn 7.76 Mn -9.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.55 Mn
Dec 31, 2025 -7.79 Mn
Sep 30, 2025 -5.89 Mn
Jun 30, 2025 -5.84 Mn
Mar 31, 2025 -6.03 Mn
Dec 31, 2024 -5.39 Mn
Sep 30, 2024 -4.97 Mn
Jun 30, 2024 -4.41 Mn
Mar 31, 2024 -4.15 Mn
Dec 31, 2023 -4.71 Mn
Sep 30, 2023 -4.90 Mn
Jun 30, 2023 -7.13 Mn
Mar 31, 2023 -5.71 Mn
Dec 31, 2022 -4.47 Mn
Sep 30, 2022 -3.80 Mn
Jun 30, 2022 -4.30 Mn
Mar 31, 2022 -3.97 Mn
Dec 31, 2021 -4.15 Mn
Sep 30, 2021 -4.04 Mn
Jun 30, 2021 -3.65 Mn